trending Market Intelligence /marketintelligence/en/news-insights/trending/8mbjz5jahhl2bsx_qdvepg2 content esgSubNav
In This List

Tetraphase Pharmaceuticals names COO

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Tetraphase Pharmaceuticals names COO

Tetraphase Pharmaceuticals Inc. promoted Larry Edwards, chief commercial officer, to the position of COO.

Edwards, who joined the company in 2015 as vice president of marketing, will also continue to oversee all aspects of pre-commercialization activities for eravacycline in complicated intra-abdominal infections.